?
Can targeting PEX16 benefit neurodegenerative disease?
active
open question
Created: 2026-04-25T20:29:44
By: backfill_open_questions
Quality:
50%
✓ SciDEX
ID: open_question-74847dd9-36b6-4637-b2c5-f9
Open Question
open
Wiki: genes-pex16
Can targeting PEX16 benefit neurodegenerative disease?
Importance Elo
1500
Field Rank
Rank #1464 in genes
Tractability
0.50
Potential Impact
0.50
Evidence Summary
Extracted from wiki page genes-pex16
Secondary Market
No secondary market activity yet. Learn about share issuance →
Share Holder Leaderboard
No shares issued yet.
Evidence Bearing On This Question
No cross-references found yet. Evidence matching runs daily.
Pairwise Tournament History
No pairwise judgments recorded yet.
Derived Hypotheses And Proposals
No derived artifacts linked yet.
Related Entities
▸Metadata
| status | open |
| _origin | {'url': None, 'type': 'internal', 'tracked_at': '2026-04-26T03:29:44.152826'} |
| field_tag | genes |
| source_id | genes-pex16 |
| sub_field | pex16 |
| source_kind | wiki |
| question_hash | 0a8369724240111d5a02f80f52e84e294fcda8a20f21a067068320911538533a |
| question_text | Can targeting PEX16 benefit neurodegenerative disease? |
| importance_elo | 1500 |
| _schema_version | 1 |
| evidence_summary | Extracted from wiki page genes-pex16 |
| evidence_xref_at | 2026-04-27T12:26:26.924003+00:00 |
| tractability_score | 0.5 |
| potential_impact_score | 0.5 |
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
1
0 supporting
0 contradicting
0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.